Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed director
CC transcript

Synaptogenix, Inc. (SNPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/25/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/16/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/28/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/15/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
04/06/2022 4 Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
04/06/2022 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
04/06/2022 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
04/06/2022 4 Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 1,500 options to buy @ $7.41, valued at $11.1k
03/29/2022 10-K Annual Report for the period ended December 31, 2021
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A HAYWOOD GEORGE WEAVER reports a 7% stake in Synaptogenix, Inc.
01/31/2022 SC 13G/A ALPHA CAPITAL ANSTALT reports a 4.5% stake in SYNAPTOGENIX, INC.
11/12/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/01/2021 8-K Quarterly results
08/13/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/13/2021 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/16/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/15/2021 4 TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 60,000 shares @ $0
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Perry George (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 40,000 shares @ $0
07/15/2021 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 45,000 shares @ $0
07/15/2021 4 WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 60,000 shares @ $0
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 90,000 shares @ $0
07/07/2021 SC 13G ALPHA CAPITAL ANSTALT reports a 5.5% stake in SYNAPTOGENIX, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy